Cerebral toxoplasmosis is a brain infection caused by the parasite Toxoplasma gondii, and it overwhelmingly strikes people whose immune systems are severely weakened. In someone with a healthy immune system, T. gondii quietly forms dormant cysts in the brain and muscles that cause no harm. But when immune defenses collapse, those cysts can reactivate into an aggressive, potentially fatal brain disease. The condition is most closely associated with advanced HIV/AIDS, though it also threatens organ transplant recipients and others on heavy immunosuppressive therapy.
How the Parasite Gets Into Your Body
Toxoplasma gondii is one of the most widespread parasites on the planet, infecting a huge range of mammals and birds as well as a substantial share of the human population. Cats are the only animals that shed the environmentally resistant form of the parasite (called oocysts) in their feces, but you do not need to own a cat to become infected. You can pick up the parasite by eating undercooked meat containing tissue cysts, by swallowing oocysts from contaminated water, soil, or unwashed produce, or through less common routes like blood transfusion, organ transplant, or unpasteurized milk.1PubMed Central. Toxoplasma gondii: from animals to humans Oocysts shed by cats can survive in the environment for months, contaminating garden soil, surface water, and food crops.2PubMed Central. Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food
A pregnant woman who catches T. gondii for the first time during pregnancy can transmit the rapidly multiplying form of the parasite (tachyzoites) to her fetus through the placenta.1PubMed Central. Toxoplasma gondii: from animals to humans This vertical transmission can cause congenital toxoplasmosis, a distinct and serious condition discussed later in this article.
What Happens Inside the Brain
After you swallow the parasite, tachyzoites spread through the bloodstream and eventually reach the brain. Getting past the blood-brain barrier is the critical step, and research in mice shows that the main entry point is at the level of tiny cortical capillaries. The parasite appears to destabilize the junctions between the cells lining those capillaries, loosening them enough to slip through.3eLife. Blood-brain barrier-restricted translocation of Toxoplasma gondii from cortical capillaries Scientists have also explored the idea that the parasite hitches a ride inside white blood cells that naturally cross the barrier, a so-called “Trojan horse” strategy, though that mechanism has so far only been demonstrated in laboratory cell models rather than in living animals.4Trends in Parasitology. Cerebral Toxoplasmosis: An Itinerary of Neuroinvasion
Once inside the brain, the immune system usually mounts a response that forces the fast-replicating tachyzoites to convert into slow-growing bradyzoites, which wall themselves off inside tissue cysts. These cysts can persist for the rest of a person’s life, sitting quietly inside neurons. If the immune system later collapses, the bradyzoites convert back into tachyzoites, triggering the destructive inflammation and tissue death that define cerebral toxoplasmosis.5PubMed Central. Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion Evidence suggests this conversion back and forth is stress-mediated, sharing biological pathways with stress-driven changes in other organisms.6PubMed Central. The development and biology of bradyzoites of Toxoplasma gondii
Who Is at Risk
The overwhelming majority of cerebral toxoplasmosis cases occur in people with advanced HIV/AIDS. A cross-sectional study at a U.S. hospital found that patients diagnosed with toxoplasma encephalitis had a median CD4 count of just 37 cells per microliter, with none higher than 210.7PubMed Central. Toxoplasmosis Encephalitis: A Cross-Sectional Analysis at a U.S. Safety-Net Hospital in the Late cART Era For context, a healthy adult typically has CD4 counts above 500. Below roughly 100, the immune surveillance that keeps dormant cysts in check essentially vanishes, and reactivation becomes a real danger.
People who receive organ or stem cell transplants face a similar risk because the drugs used to prevent rejection also suppress the immune response that holds T. gondii in check. In one series of 170 patients who received donor stem cells, about 3% developed cerebral toxoplasmosis.8Transplant Infectious Disease. Analysis of cerebral toxoplasmosis in a series of 170 allogeneic hematopoietic stem cell transplant patients That figure may sound small, but the consequences of the disease are severe enough that transplant teams routinely screen for prior Toxoplasma exposure and consider preventive medication.
People on other forms of heavy immunosuppression, such as high-dose corticosteroids or chemotherapy for cancer, can also be vulnerable, though cases are less common than in the HIV and transplant populations.
Symptoms and How They Appear
Cerebral toxoplasmosis usually develops over days to a couple of weeks rather than striking overnight. The classic presentation includes headache, fever, confusion, and focal neurological problems that depend on where in the brain the lesions form.9PubMed Central. Stroke-Like Presentation of Cerebral Toxoplasmosis: Two HIV-Infected Cases In a study of patients with AIDS in Mexico, most had headache along with weakness on one side of the body or seizures.10PubMed. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico
Common symptoms include:
- Headache: often the earliest and most prominent complaint, sometimes severe
- Weakness or numbness: typically affecting one side of the body, sometimes mimicking a stroke
- Seizures: may be the very first sign that brings someone to the emergency department
- Confusion or altered consciousness: ranging from mild disorientation to coma in advanced cases
- Fever: not always present, but common
- Speech or vision problems: depending on lesion location
Because the symptoms can look exactly like a stroke or a brain tumor, cerebral toxoplasmosis is sometimes not recognized immediately, particularly in someone who does not yet know they are living with HIV. One published case described a middle-aged woman who presented with seizure-like activity and turned out to have ring-enhancing brain lesions; her HIV infection had never been diagnosed before that visit.11PubMed Central. A Headache and an Abscess: A Case of Cerebral Toxoplasmosis
Diagnosis and the Imaging Puzzle
When a doctor suspects cerebral toxoplasmosis, the first step is usually a contrast-enhanced MRI of the brain. The hallmark finding is multiple ring-enhancing lesions, areas where a rim of tissue lights up with contrast dye surrounding a darker center of dead or necrotic tissue.12PubMed Central. The Radiological Mimicry of Ring-Enhancing Lesions: Cerebral Toxoplasmosis Masquerading as Metastatic Disease These lesions tend to cluster in the basal ganglia and at the junction between the brain’s gray and white matter, though they can appear almost anywhere.
One distinctive imaging pattern is the “eccentric target sign,” where a small bright knot sits off-center within the ring. Pathology studies have shown that this central enhancing core corresponds to a cluster of inflamed blood vessels running down a brain fold, surrounded by concentric zones of tissue death and a wall of immune cells and new blood vessels whose leaky walls produce the outer ring.13PubMed Central. Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature
Blood tests for Toxoplasma antibodies help frame the picture. Most patients with cerebral toxoplasmosis test positive for IgG antibodies, reflecting a past infection that has now reactivated. A negative IgG makes the diagnosis less likely but does not rule it out entirely, since profoundly immunosuppressed patients sometimes fail to produce detectable antibodies.
The Lymphoma Look-Alike Problem
The biggest diagnostic headache is distinguishing cerebral toxoplasmosis from primary central nervous system lymphoma, a type of brain cancer that is the second most common cause of brain masses in HIV patients.14PubMed Central. Acute Presentation of Primary CNS Lymphoma Mimicking Toxoplasma in HIV Infection Both conditions produce ring-enhancing lesions, both cause similar neurological symptoms, and both appear in the same severely immunosuppressed population. Getting the distinction right matters enormously: toxoplasmosis is treated with antibiotics, while CNS lymphoma requires chemotherapy. Untreated CNS lymphoma has a survival time measured in months.
Advanced imaging techniques such as PET scans can help, because lymphoma tends to be much more metabolically active than a toxoplasma abscess.15PubMed. Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CT In practice, many clinicians start anti-toxoplasma treatment empirically and watch for improvement on repeat imaging over about two weeks. If the lesions shrink, that response itself is considered strong evidence that the diagnosis was toxoplasmosis. If the lesions do not improve or get worse, a brain biopsy may be needed to look for lymphoma or other causes.
PCR Testing of Spinal Fluid
Testing cerebrospinal fluid (CSF) for T. gondii DNA using a polymerase chain reaction (PCR) test can add another piece of the diagnostic puzzle. One Brazilian study of AIDS patients reported 100% sensitivity and about 94% specificity when PCR was performed on CSF samples.16PubMed Central. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients Other studies have found somewhat lower sensitivity. The test performs best when the spinal fluid is collected before or within the first week of anti-toxoplasma treatment; after a week of therapy, the test often turns negative, which makes sense since the drugs are killing off the parasite and reducing the amount of detectable DNA.17PubMed. Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients
When both CSF and blood samples are tested together, the combined results can push specificity to 100% in some studies, though sensitivity still hovers in the mid-to-high 70s in less favorable settings.18PubMed Central. Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients In other words, a positive PCR strongly supports the diagnosis, but a negative one does not confidently exclude it. Clinicians typically weigh PCR results alongside imaging, serology, and the patient’s clinical picture.
Treatment
The standard first-line therapy combines two antiparasitic drugs, pyrimethamine and sulfadiazine, given together with folinic acid to protect the bone marrow from pyrimethamine’s side effects. A randomized trial in AIDS patients found this combination to be the most effective treatment option tested.19PubMed. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients Treatment is divided into two phases: an initial “induction” phase lasting at least six weeks at higher doses, followed by a long-term “maintenance” phase at lower doses to prevent relapse.
A significant number of patients cannot tolerate sulfa drugs because of allergic reactions, rashes, or kidney problems. For these patients, clindamycin combined with pyrimethamine is the main alternative. A randomized trial comparing this combination to the standard pyrimethamine-sulfadiazine regimen found the two were roughly equivalent in effectiveness.20PubMed. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine In resource-limited settings where pyrimethamine itself may be hard to obtain, clindamycin alone has been used successfully in individual cases, although this approach is not backed by the same level of evidence.21PubMed Central. Successful treatment of cerebral toxoplasmosis with clindamycin: a case report
For patients with HIV, starting or optimizing antiretroviral therapy is just as important as the anti-toxoplasma drugs. Rebuilding the immune system is ultimately what keeps the infection from coming back once maintenance therapy is eventually stopped.
Steroids and Managing Brain Swelling
Brain swelling around the toxoplasma lesions can raise pressure inside the skull and worsen neurological symptoms. Corticosteroids like dexamethasone can reduce that swelling, but they also further suppress the immune system, which is already the root problem. Current guidance therefore reserves steroids for patients who have significant mass effect or dangerous levels of brain edema rather than using them routinely.22PubMed Central. Significant clinical outcome using pyrimethamine and clindamycin in cerebral toxoplasmosis with severe edema: a case report
A study looking at neurological outcomes in HIV patients with severe cerebral toxoplasmosis found that adjunctive steroid use appeared safe but was not associated with better outcomes compared to anti-toxoplasma therapy alone.23PubMed. Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis Steroids also complicate the diagnostic picture: because both toxoplasmosis and CNS lymphoma can temporarily shrink with steroid treatment, giving steroids before the diagnosis is settled can muddy the waters. Whenever possible, clinicians prefer to establish the diagnosis first.
The IRIS Complication
Paradoxically, some patients get worse just as their immune system starts recovering. This happens in a phenomenon called immune reconstitution inflammatory syndrome, or IRIS. When antiretroviral therapy drives CD4 counts back up, the newly restored immune cells can launch an exaggerated inflammatory attack against the parasite cysts in the brain, causing new or worsening lesions even though the anti-toxoplasma treatment is working.24HIV & AIDS Review. Toxoplasma gondii: A rare pathogen causing a neurological immune inflammatory reconstitution syndrome in HIV infected patient
IRIS can be alarming because repeat imaging shows new brain lesions at a moment when the patient should theoretically be improving. Distinguishing IRIS from genuine treatment failure is key, since the management differs: IRIS is usually treated with corticosteroids to tamp down the excessive inflammatory response, while the anti-toxoplasma drugs and antiretrovirals are continued. In one transplant-related case, spinal fluid PCR turned negative even as new lesions appeared on MRI, supporting the interpretation that the worsening was immune-driven rather than parasitic.25Mayo Clinic Proceedings. Cerebral Toxoplasmosis-Associated Immune Reconstitution Inflammatory Syndrome After Allogeneic Hematopoietic Stem Cell Transplant Although T. gondii is considered an uncommon trigger for neuro-IRIS compared to organisms like tuberculosis or cryptococcus, clinicians watching over newly treated HIV patients need to keep it on the radar.
Congenital Toxoplasmosis and the Brain
Cerebral toxoplasmosis takes a different form when infection occurs before birth. A woman who has never been infected with T. gondii and encounters the parasite for the first time during pregnancy can pass tachyzoites to the developing fetus. The consequences depend heavily on when in pregnancy the infection happens. An earlier-pregnancy infection tends to cause more severe damage because the fetal brain is still forming, though the transmission rate is actually higher later in pregnancy when placental blood flow is greater.26PubMed. Congenital toxoplasmosis: An overview of the neurological and ocular manifestations
The classic triad of congenital toxoplasmosis includes brain calcifications visible on imaging, hydrocephalus (fluid buildup in the brain), and inflammation of the retina. A study of 31 cases found a clear relationship between the severity of brain lesions seen on CT scan and the timing of maternal infection.27PubMed. Congenital toxoplasmosis. Clinical and neuroradiological evaluation of the cerebral lesions Not all babies follow the textbook pattern, however. One recent case report described an infant with hydrocephalus and ring-enhancing brain lesions but no calcifications at all, along with eye inflammation affecting both sides.28PubMed Central. Congenital Toxoplasmosis With Atypical Neuroimaging: Hydrocephalus and Bilateral Chorioretinitis Without Intracranial Calcifications These atypical presentations mean that clinicians cannot rely on the presence of calcifications alone to confirm or exclude the diagnosis.
How the Parasite Rewires the Brain
Even outside the context of full-blown cerebral toxoplasmosis, the dormant cysts that T. gondii forms in the brain are not entirely silent. Research has shown that the parasite alters how neurons function and globally disrupts signaling pathways in the brain.29PubMed Central. Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection Much of the early attention to this phenomenon came from animal studies showing that infected rodents lose their innate fear of cat odors, a behavioral change that conveniently makes them more likely to be caught and eaten, completing the parasite’s life cycle.
In humans, the story is more nuanced and more contentious. Chronic T. gondii infection has been statistically linked to subtle changes in behavior, reaction times, and even personality traits in some studies, as well as a modestly increased risk of certain psychiatric conditions. The proposed mechanisms involve the parasite’s effect on neurotransmitter levels and the ongoing low-grade immune response the brain mounts against the cysts.30PubMed. Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders T. gondii can produce an enzyme involved in the synthesis of dopamine, and the chronic inflammation it triggers affects other brain chemicals as well. The field is still debating how large these effects truly are in people, though, and whether they translate into clinically meaningful consequences for the roughly one-third of the world’s population that carries dormant cysts.
This line of research blurs the boundary between “infection” and “behavioral biology” in a way that fascinates parasitologists and neuroscientists alike. Understanding exactly how a single-celled organism can alter the behavior of its host, whether that host is a mouse or a human, remains one of the more provocative open questions in infectious disease science.